Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunyang Xie

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 9, 2023
Protective effect of the novel cyclic peptide ASK0912 on mice with sepsis induced by Acinetobacter baumanniiChunyang Xie, Penghe Wang, Huige Wu, et al.
Journal for Immunotherapy of Cancer|March 4, 2026
Oncolytic virotherapy potentiates chemo-PD-1 immunotherapy by engaging chemo-resistant bystander CD8<sup>+</sup> T cellsYang Yang, Junjian He, Texi Liang, et al.
Molecules (Basel, Switzerland)|December 11, 2022
The Anti-Multidrug-Resistant <i>Acinetobacter baumannii</i> Study on 1,3-diamino-7H-pyrrolo[3,2-f]quinazoline CompoundsHan Wu, Hongtong Chen, Jungan Zhang, et al.
Acta Pharmaceutica Sinica. B|September 18, 2023
Polymyxin resistance caused by large-scale genomic inversion due to IS<i>26</i> intramolecular translocation in <i>Klebsiella pneumoniae</i>Haibin Li, Lang Sun, Han Qiao, et al.
Acta Biomaterialia|June 20, 2024
Negatively charged nanodiscs for the reduction of toxicity and enhanced efficacy of polymyxin B against Acinetobacter baumannii sepsisPenghe Wang, Chunyang Xie, Youwen Zhang, et al.
Cell Reports|March 28, 2026
Regulatory T cell-derived TGF-β signaling governs the differentiation and maintenance of tumor-infiltrating bystander CD8<sup>+</sup> T cellsYao Lin, Shuai Yue, Ding Qiu, et al.
Molecular Therapy. Oncology|April 30, 2026
Oncolytic virotherapy mobilizes tumor-resident, granzyme B-producing bystander CD4<sup>+</sup> T cells to inhibit systemic microbial infectionShuai Yue, Junjian He, Shusen Ye, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 9, 2023
Protective effect of the novel cyclic peptide ASK0912 on mice with sepsis induced by Acinetobacter baumanniiChunyang Xie, Penghe Wang, Huige Wu, et al.
Journal for Immunotherapy of Cancer|March 4, 2026
Oncolytic virotherapy potentiates chemo-PD-1 immunotherapy by engaging chemo-resistant bystander CD8<sup>+</sup> T cellsYang Yang, Junjian He, Texi Liang, et al.
Molecules (Basel, Switzerland)|December 11, 2022
The Anti-Multidrug-Resistant <i>Acinetobacter baumannii</i> Study on 1,3-diamino-7H-pyrrolo[3,2-f]quinazoline CompoundsHan Wu, Hongtong Chen, Jungan Zhang, et al.
Acta Pharmaceutica Sinica. B|September 18, 2023
Polymyxin resistance caused by large-scale genomic inversion due to IS<i>26</i> intramolecular translocation in <i>Klebsiella pneumoniae</i>Haibin Li, Lang Sun, Han Qiao, et al.
Acta Biomaterialia|June 20, 2024
Negatively charged nanodiscs for the reduction of toxicity and enhanced efficacy of polymyxin B against Acinetobacter baumannii sepsisPenghe Wang, Chunyang Xie, Youwen Zhang, et al.
Cell Reports|March 28, 2026
Regulatory T cell-derived TGF-β signaling governs the differentiation and maintenance of tumor-infiltrating bystander CD8<sup>+</sup> T cellsYao Lin, Shuai Yue, Ding Qiu, et al.
Molecular Therapy. Oncology|April 30, 2026
Oncolytic virotherapy mobilizes tumor-resident, granzyme B-producing bystander CD4<sup>+</sup> T cells to inhibit systemic microbial infectionShuai Yue, Junjian He, Shusen Ye, et al.
Pageof 2